Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
Dare Bioscience, Inc. issued 195,010 Investor Units, each consisting of one share of Series A Convertible Preferred Stock and two Investor Warrants to purchase up to 390,020 shares of commo of unit to public investors in Regulation A offering for at an offering price of $5.00 per unit.
- Security
- unit
- Shares
- 195,010 Investor Units, each consisting of one share of Series A Convertible Preferred Stock and two Investor Warrants to purchase up to 390,020 shares of commo
- Purchaser
- public investors in Regulation A offering
- Consideration
- at an offering price of $5.00 per unit
Exact text from the filing
completed closings of its previously announced Regulation A offering of up to 4,854,000 units (each, an “Investor Unit” and collectively the “Investor Units”), each consisting of one share of Series A Convertible Preferred Stock (the “Series A Preferred Stock”) and two warrants, each to purchase one share of our common stock (“Investor Warrants”), with each Investor Unit being offered at an offering price of $5.00 (the “Offering”). The closings occurred on each of May 1, 4, 5 and 6, 2026. In connection therewith, we issued an aggregate of 195,010 Investor Units consisting of 195,010 shares of Series A Preferred Stock and Investor Warrants to purchase up to 390,020 shares of our common stock.
View on SEC.gov